Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000239325 | SCV000297189 | uncertain significance | not specified | 2015-10-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422165 | SCV004144941 | benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | DNASE1: BS1, BS2 |
Clinical Genomics Laboratory, |
RCV004555859 | SCV005045153 | uncertain significance | Systemic lupus erythematosus | 2023-12-26 | criteria provided, single submitter | clinical testing | The DNASE1 c.619C>T (p.Arg207Cys) variant, to our knowledge, has not been reported in the medical literature. The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.36% in the South Asian population, which is higher than the expected incidence of systemic lupus erythematosus. Computational predictors are uncertain as to the impact of this variant on DNASE1 function. This variant has been reported in the ClinVar database as a germline variant by two submitters, one as a variant of uncertain significance and one as benign due to the high allele frequency. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |
Breakthrough Genomics, |
RCV003422165 | SCV005194179 | uncertain significance | not provided | criteria provided, single submitter | not provided |